Correctsequence's experimental gene-editing therapy CS-101 has been used to treat a person with SCD for the first time.

ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, is highlighting the recent European Heart Journal publication of SCD-PROTECT, an independent clinical ...

The code “left against medical advice” should be recognized as a sentinel event—a preventable system failure that signals unmet care needs.

Children with sickle cell disease (SCD) had more emergency department (ED) visits if their parents had a greater number of adverse childhood experiences (ACEs) than if their parents had fewer ACEs ...

An intervention to improve hydroxyurea adherence may improve quality of life in teens with SCD, according to an analysis of ...